Sign Out
Pregnancy: Pregnancy Category B.
There is no evidence of teratogenic effect from animal reproduction studies and there are no adequate and well-controlled studies in pregnant women. However, Tranexamic acid crosses the placenta and appears in cord blood. Tranexamic acid should only be used during pregnancy if considered essential.
Lactation: Tranexamic acid is present in the mother's milk at a concentration of about one hundredth of the corresponding serum concentration (Data: One hour after the last dose following a 2-day treatment course in lactating women, the milk concentration of the Tranexamic acid was 1% of the peak serum concentration).
There are no adequate data on the effects of Tranexamic acid on the breastfed infant or the effects of Tranexamic acid on milk production. Tranexamic acid should only be used during breastfeeding if considered essential.
Continue with Google